Shanghai Universal Biotech (301166.SZ) issued a profit warning, with an expected annual net profit of 8-12 million yuan, a year-on-year decrease of 70.24%-80.16%.

Shanghai Universal Biotech (301166.SZ) disclosed its performance forecast for the year 2024, with the company expecting a net profit attributable to shareholders of the listed company of 8 to 12 million yuan, a year-on-year decrease of 70.24%-80.16%; and a net loss of 13.24 to 17.24 million yuan after excluding non-recurring gains and losses.